BW
BSGAU

Boaz Weinstein’s Blue Safari Group Acquisition Corp. Unit BSGAU Stock Holding History

Boaz Weinstein’s Portfolio BSGAU Stock Details BSGAU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-200,000
Closed -$1.99M – 553
2021
Q2 		$1.99M Buy
+200,000
New +$2M 0.06% 286

Other funds holding BSGAU

YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return

Boaz Weinstein's BSGAU Position: Q3 2021 in Review

Boaz Weinstein sold out of Blue Safari Group Acquisition Corp. Unit (BSGAU) in Q3 2021, closing a stake of 200,000 shares — an estimated $1.99M sold.

Boaz Weinstein first reported a position in BSGAU in Q2 2021 and held it in 1 quarter. The position peaked at $1.99M in Q2 2021. 8 funds tracked by Wall St. Rank hold BSGAU as of Q3 2021.

  • Boaz Weinstein reported no remaining Blue Safari Group Acquisition Corp. Unit position as of Q3 2021 after selling out during the quarter.
  • Boaz Weinstein sold 200,000 Blue Safari Group Acquisition Corp. Unit shares in Q3 2021, an estimated $1.99M.
  • Boaz Weinstein first reported a position in Blue Safari Group Acquisition Corp. Unit in Q2 2021 and held it in 1 quarter.
  • Boaz Weinstein's Blue Safari Group Acquisition Corp. Unit position peaked at $1.99M in Q2 2021.
  • 8 funds tracked by Wall St. Rank held Blue Safari Group Acquisition Corp. Unit as of Q3 2021.

Based on Saba Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.